ICCT.OTC.PinkIcoreconnect INC

DEF 14A: iCoreConnect Seeks Stockholder Approval for Multiple Share Issuance Proposals to Comply with Nasdaq Listing Rules

Sentiment:

Proxy Statement


iCoreConnect is holding a special meeting of stockholders on September 16, 2024, to vote on five proposals related to the issuance of common stock to comply with Nasdaq Listing Rules.

Delay expectedThe company failed to file its Form 10-K on a timely basis, leading to events of default under the Notes.There were delays in registering the resale of the common stock underlying the Notes issued in February 2024.
Capital raiseThe company is seeking approval for the issuance of shares related to a $5.0 million commitment from Clearthink Capital Partners.The company is also seeking approval for the issuance of shares related to the conversion of convertible notes.
Worse than expectedThe proposals, if approved, will lead to significant dilution of existing shareholders' ownership, which is generally viewed negatively by the market.

Summary

  • iCoreConnect is convening a Special Meeting of Stockholders on September 16, 2024, to vote on five proposals.
  • The proposals primarily concern the issuance of common stock to comply with Nasdaq Listing Rule 5635(d).
  • Proposal 1 seeks approval for the issuance of up to 11,203,700 shares upon the exercise of warrants issued on July 31, 2024.
  • Proposal 2 concerns the issuance of shares upon conversion of an amended convertible note, amended as of August 13, 2024.
  • Proposal 3 relates to the issuance of shares pursuant to the Strata Purchase Agreement dated August 16, 2024, with Clearthink Capital Partners, LLC.
  • Proposal 4 involves the issuance of shares upon conversion of convertible notes dated August 1, 2024, issued in connection with the exchange and/or extension of certain outstanding indebtedness.
  • Proposal 5 is to approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the above proposals.
  • The Board of Directors unanimously recommends voting FOR all proposals.

Sentiment

Score: 4

Explanation: The document is primarily factual and procedural, but the need for multiple proposals to issue shares and the potential for dilution suggest underlying financial challenges. The reliance on potentially dilutive financing mechanisms is a concern.

Positives

  • Approval of the proposals would allow iCoreConnect to comply with Nasdaq Listing Rules.
  • Approval of the proposals would enable the company to access financing through warrant exercises, convertible notes, and the Strata Purchase Agreement.
  • The Strata Agreement can be terminated by iCoreConnect at any time without cost or penalty.

Negatives

  • Approval of the proposals will likely result in dilution of existing stockholders' ownership.
  • The sale of a significant amount of common stock by Clearthink could cause the market price of iCoreConnect's common stock to decline and be highly volatile.
  • Failure to approve the proposals could require iCoreConnect to repay notes in cash, diverting resources from operations.

Risks

  • The market price of iCoreConnect's common stock could be adversely affected by the issuance of new shares.
  • Existing stockholders' ownership will be diluted if the proposals are approved.
  • Failure to obtain stockholder approval could limit the company's financing options and require cash repayments of debt.
  • The conversion price of the May Note and the purchase price under the Strata Agreement are variable and dependent on the market price of iCoreConnect's common stock.

Future Outlook

The company expects that any proceeds received from sales to Clearthink will be used for working capital and general corporate purposes.

Management Comments

  • The Company's Board has determined that each of the proposals that will be presented to the stockholders for their consideration at the Special Meeting are in the best interests of the Company and its stockholders, and unanimously recommends and urges you to vote FOR the proposals set forth in this Proxy Statement.
  • Robert P. McDermott, Chairman of the Board and Chief Executive Officer, thanks stockholders for their continued support.

Industry Context

Many small-cap companies use similar financing methods, such as convertible notes and equity lines of credit, to raise capital. Compliance with Nasdaq listing rules is crucial for maintaining the company's listing status and access to public markets.

Comparison to Industry Standards

  • The use of convertible notes and warrants is a common financing strategy for small-cap companies, particularly in the technology and healthcare sectors.
  • The terms of the Strata Purchase Agreement, including the discount to market price and the commitment amount, are generally consistent with similar equity line of credit facilities.
  • The potential dilution from the proposed share issuances is a typical concern for existing shareholders in these types of transactions.

Stakeholder Impact

  • Shareholders will be impacted by potential dilution of their ownership.
  • Employees may be impacted by the company's ability to secure financing for operations.
  • The company's creditors may be impacted by the company's ability to repay its debts.

Next Steps

  • Stockholders need to vote on the proposals before the Special Meeting on September 16, 2024.
  • The company will file a Form 8-K with the SEC to disclose the voting results within four business days after the Special Meeting.
  • The company needs to file a registration statement covering the resale by Clearthink of the shares of common stock purchased from the company.

Key Dates

DateDescription
February 26, 2024Execution of securities purchase agreements for the Note Financing.
April 26, 2024Amendment to the Purchase Agreements, increasing the total amount of notes issuable.
July 18, 2024Record date for the Special Meeting of Stockholders.
July 31, 2024Issuance of warrants to investors in consideration for waiving certain events of default.
August 1, 2024Effective date of exchange agreements and convertible promissory notes (Exchange Notes).
August 1, 2024Effective date of securities purchase agreements and new convertible promissory notes (2027 Notes).
August 1, 2024Effective date of securities purchase agreements and new convertible promissory notes (2025 Notes).
August 7, 2024Ms. Hyland was appointed to the Board.
August 13, 2024Amendment of the May Note conversion price.
August 16, 2024Execution of the Strata Purchase Agreement with Clearthink Capital Partners, LLC.
September 5, 2024Date of the Proxy Statement.
September 15, 2024Deadline for voting over the Internet or by telephone (11:59 P.M. Eastern Time).
September 16, 2024Special Meeting of Stockholders to be held online at 9:00 a.m. Eastern Time.

Keywords

iCoreConnect, stockholder approval, Nasdaq Listing Rule 5635(d), common stock issuance, warrants, convertible notes, Strata Purchase Agreement, Clearthink Capital Partners, dilution, financing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.